Cryochambers are used to induce awhole body cryotherapeutic response. According to the WHO nomenclature ofmedical devices, cryosurgical units for general purpose are covered under UMDNScode 11-067, 18-051.
EuropeCryochambers Market is estimated to account for US$ 53.1 Mn in terms ofvalue in 2019 and is expected to reach US$ 76.5 Mn by the end of 2027.
Europe Cryochambers Market:Drivers
Increasing number of cryotherapyestablishments is expected to boost growth of Europe cryochambers market overthe forecast period. For instance, Glass House Retreat, a purpose-built spa,detox and weight loss retreat in the U.K, houses a cryotherapy chamber.
Europe Cryochambers Market:Opportunities
Development of novel sensors tomonitor the depth of frozen skin tissue is expected to offer a lucrative growthopportunities for players in the market. For instance, in February 2020,researchers at University of Ioannina, Greece, reported development of anoptical fiber-array sensor to monitor the depth of frozen skin tissue duringfreezing–thawing cycles in cryosurgery.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3628
Europe Cryochambers Market:Restraints
Adverse effects of cryotherapyare expected to hamper growth of Europe cryochambers market. Modern cryogenicchambers use mixture of 21% oxygen and 79% nitrogen to achieve and maintain thenear-cryogenic temperatures in the system. However, this exposes patients tovariety of risks and physiological hazards of evaporation of tissue water andoxygen deficiency. Exposure to sub-zero temperatures in cryochambers may leadto hypothermia, inert gas asphyxiation, frostbites (cold burn), numbness &irritation of the skin, nerve damage, eye injury from the extreme lowtemperatures or even death in rare cases.
Key Takeaways:
Cryochambers segment in EuropeCryochambers market was valued at US$ 31.3 Mn in 2018 and is expected to reachUS$ 49.4 Mn by 2027 at a CAGR of 5.4% during the forecast period. Increasingnumber of non-invasive and minimally-invasive procedures performed every yearis expected to be the major driving force for the segment growth in the nearfuture. Factors such as presence of established cryotherapy companies, presenceof skilled professionals, and increasing awareness about the therapy isexpected to support growth of the segment.
The Dermatology & BeautyApplications segment held dominant position in Europe cryochambers market in2018, accounting for 46.7% share in terms of value, followed by Sports Medicine& Pain Management and Others, respectively. The demand for non-invasive andminimally invasive procedures is increasing exponentially owing to increasingconsumer preference on enhancing one’s physically features, and treating skinproblems. The incidence of both non-melanoma and melanoma skin cancers has beenincreasing over the past decades. According to the World Health Organization’s2018 health statistics, around 2 to 3 million cases of non-melanoma skincancers, and 132,000 melanoma skin cancers occur globally each year.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/europe-cryochambers-market-3628
Market Trends
Cryotherapy can be effectiveduring knee replacement surgery to maintain the surgical area at the desiredtemperature. Moreover, postoperative cryotherapy can aid in reducing pain,bleeding, length of stay, analgesic requirement and swelling after total kneearthroplasty.
Use of whole-body cryotherapy canaid reducing blood levels of asprosin in menopausal women. Moreover,cryotherapy does not significantly affect insulin concentration or insulinresistance.
Europe Cryochambers Market:Competitive Landscape
Major players in Europecryochambers include, Zimmer MedizinSysteme GmbH, KrioSystem Sp. z.o.o, AirProducts and Chemicals, Inc., CSA Medical, Inc., METRUM CRYOFLEX Sp. z o.o.,Sp. K., Novotech S.R.O, CryoAction Limited, JUKA SP. Z.O.O. SP.K., Cryosense,and CRYO Science.
Europe Cryochambers Market: KeyDevelopments
August 2019: BTG InternationalCanada Inc., a part of BTG plc., a global specialist healthcare company,received a medical device license from Health Canada for the ICEfx CryoablationSystem
January 2019: CRYO Science, inpartnership with Canopy Environmental, announced that the U.S. Air Force'sspecial tactical unit incorporated the CRYO Arctic Whole Body CryotherapyChamber into their squadron at Joint Base Lewis-McChord, Washington
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3628
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
